Ordinance
on Licensing in the Medicinal Products Sector
(Medicinal Products Licensing Ordinance, MPLO)

English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.

of 14 November 2018 (Status as of 28 January 2022)


Open article in different language:  DE  |  FR  |  IT
Art. 8 Cantonal manufacturing licence

1 Hos­pit­al phar­macists and per­sons in pos­ses­sion of a can­ton­al li­cence in ac­cord­ance with Art­icle 30 TPA who pre­pare medi­cin­al products in ac­cord­ance with Art­icle 9 para­graph 2 let­ters a–cbis or para­graph 2bis TPA must carry out a risk as­sess­ment in ac­cord­ance with An­nex 3. This pro­vi­sion does not ap­ply to the cases set out in para­graph 6 be­low.

2 The con­duct of these risk as­sess­ments should be doc­u­mented. This doc­u­ment­a­tion should be presen­ted to the can­ton­al su­per­vis­ory au­thor­ity on re­quest.

3 If the risk as­sess­ment pro­duces a value be­low the threshold spe­cified in An­nex 3, a can­ton­al man­u­fac­tur­ing li­cence is re­quired in­stead of a li­cence is­sued by Swiss­med­ic.

4 The li­cence is gran­ted if it can be en­sured that the rules of Good Man­u­fac­tur­ing Prac­tice for small quant­it­ies of medi­cin­al products in ac­cord­ance with An­nex 2 are ob­served.

5 The can­tons reg­u­late the oth­er con­di­tions for the grant­ing of the li­cence in ac­cord­ance with para­graph 3 and peri­od­ic­ally carry out fa­cil­ity checks.

6 Any per­son who man­u­fac­tures ra­dio­phar­ma­ceut­ic­als re­quires a li­cence gran­ted by Swiss­med­ic.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden